ALXN

Alexion Pharmaceuticals, Inc.

No insider bought or sold Alexion Pharmaceuticals, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow ALXN

ALXN over the last year

Prices for ALXN aren't in yet.

ALXN after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

95 insider filings since 2016, newest first

ALXNSell

Daniel Bazarko · SVP, Controller, CAO

$3.8M−44.0%Dec 21

ALXNSell

Tanisha Carino · EVP, CCAO

$187K−9.0%Dec 4

ALXNSell

Indrani Lall Franchini · EVP and Chief Compliance Officer

$786K−20.0%Jun 9

ALXNBuy

Baker Bros. Advisors LP · Director

$32.8M+6.0%Mar 18

ALXNBuy

Baker Bros. Advisors LP · Director

$6.7M+1.0%Mar 18

ALXNSell

Indrani Lall Franchini · EVP and Chief Compliance Officer

$598K−13.0%Jul 2

ALXNSell

Aradhana Sarin · Chief Strategy, Business Off

$76K−2.0%Jun 24

ALXNSell

Baker Bros. Advisors LP · Director

$37.1M−4.0%May 30

ALXNSell

Daniel Bazarko · SVP, Controller, CAO

Ludwig Hantson · CEO

Indrani Lall Franchini · EVP and Chief Compliance Officer

$308K−8.0%Nov 30

ALXNSell

Paul J Clancy · EVP and CFO

$687K−5.0%Jul 12

ALXNSell

Brian Goff · EVP and Chief Commercial Officer

$195K−4.0%Jun 12

ALXNSell

Indrani Lall Franchini · EVP and Chief Compliance Officer

$174K−4.0%Jun 12

ALXNSell

Anne-Marie Law · EVP and CHRO

$221K−6.0%Jun 12

ALXNSell

John J Orloff · EVP, Research, Development

$251K−6.0%Jun 12

ALXNBuy

Christopher J Coughlin · Director

$1.2M+61.0%May 2

ALXNSell

Julie O'Neill · EVP. Global Operations

$195K−4.0%Mar 1

ALXNSell

Heidi L Wagner · SVP, Global Government Affairs

$83K−1.0%Mar 1

ALXNSell

Brian Goff · EVP and Chief Commercial Officer

$192K−5.0%Feb 8

ALXNSell

Julie O'Neill · EVP. Global Operations

Ludwig Hantson · CEO

Heidi L Wagner · SVP, Global Government Affairs

$206K−3.0%Feb 8

ALXNSell

Paul J Clancy · EVP and CFO

$707K−6.0%Feb 8

ALXNSell

Indrani Lall Franchini · EVP and Chief Compliance Officer

$170K−6.0%Feb 8

ALXNSell

John B Moriarty · EVP and General Counsel

$389K−4.0%Feb 8

ALXNSell

Julie O'Neill · EVP. Global Operations

$248K−9.0%Feb 7

ALXNSell

Heidi L Wagner · SVP, Global Government Affairs

$77K−2.0%Feb 7

ALXNSell

John B Moriarty · EVP and General Counsel

Ludwig Hantson · CEO

Julie O'Neill · EVP. Global Operations

$636K−16.0%Sep 5

ALXNSell

Ann M Veneman · Director

$122K−13.0%Sep 5

ALXNSell

Julie O'Neill · EVP. Global Operations

$1.6M−29.0%Aug 30

ALXNSell

Ann M Veneman · Director

$96K−10.0%Aug 2

ALXNSell

Alvin S Parven · Director

$98K−10.0%Jun 16

ALXNSell

Julie O'Neill · EVP. Global Operations

$87K−2.0%Mar 6

ALXNSell

Carsten Thiel · EVP and Chief Commercial Officer

$496K−10.0%Mar 6

ALXNSell

Julie O'Neill · EVP. Global Operations

$207K−4.0%Mar 1

ALXNSell

Martin Mackay · EVP, Global Head of R, D

$244K−4.0%Mar 1

ALXNSell

John B Moriarty · EVP and General Counsel

$238K−3.0%Mar 1

ALXNSell

Edward Miller · SVP and Chief Compliance Officer

$78K−3.0%Mar 1

ALXNSell

Clare Carmichael · EVP and CHRO

$287K−5.0%Mar 1

ALXNSell

Heidi L Wagner · SVP, Global Government Affairs

$131K−3.0%Mar 1

ALXNSell

Leonard Bell · Director

$525K−1.0%Mar 1

ALXNSell

Martin Mackay · EVP, Global Head of R, D

$28K−1.0%Feb 10

ALXNSell

Leonard Bell · Director

$31KFeb 10

ALXNSell

Julie O'Neill · EVP. Global Operations

$351K−8.0%Feb 8

ALXNSell

Martin Mackay · EVP, Global Head of R, D

$343K−6.0%Feb 8

ALXNSell

Clare Carmichael · EVP and CHRO

$449K−9.0%Feb 8

ALXNSell

John B Moriarty · EVP and General Counsel

$445K−7.0%Feb 8

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.